CEACAM5 and colorectal carcinoma: Furthermore, the 5-year survival rates of cases across all stages of CRC with negative CD44v9 mRNA expression and low CEA were better than those in other cases (92.1% vs. 65.4%, p < 0.001; Figure 6).